High dose vitamin D may not affect COVID-19 severity or number of hospital visits, however, it may slightly reduce the ...
In a large, randomized trial, researchers at Mass General Brigham have found that high-dose vitamin D3 did not reduce COVID-19 infection severity, but may impact long COVID outcomes.
Higher doses of vitamin D3 supplementation did not significantly reduce cardiac biomarkers in older adults with low serum vitamin D levels. The STURDY trial found no significant differences in ...
In a large, randomized trial, researchers at Mass General Brigham found that high-dose vitamin D3 did not reduce COVID-19 ...
High-dose Vitamin D doesn't reduce acute COVID severity but shows a promising signal for reducing Long COVID and brain fog.
Research Continues to Reinforce the Importance of Consistent Vitamin D Intake for Immune Support. SYNEVIT®'s Vitamin D Supplement Addresses the Need. Vitamin D deficiency is a worldwide concern. It is ...
A double-blind randomized phase 3 clinical trial led by Dana-Farber Cancer Institute researchers and conducted across several hundred cancer centers in the U.S. tested the addition of high-dose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results